Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05487820
Other study ID # DIMENSION
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 13, 2023
Est. completion date October 1, 2025

Study information

Verified date October 2023
Source Oslo University Hospital
Contact Magne Røkkum, MD, Ph.D
Phone 90839385
Email magne.rokkum@medisin.uio.no
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators will test if changes in CO2 is detected postoperatively in ischemic tissue in a reconstructed flap. IscAlert is measuring continuously CO2 in muscular and subcutaneous tissue. IscAlert is inserted distal to the operative field into normal muscle and/or subcutaneous tissue in the reconstructed flap. Local tissue CO2 and temperature will be monitored continuously postoperatively until maximal 10 days. If a reduced or totally obstructed blood flow appear (thrombosis), an increase in tissue CO2 and a lower local temperature will emerge rapidly as a sign of ischemia. This will be detected by the sensor which will alarm the investigators. This will lead to assessment of the reconstructed flap and if restricted blood flow is diagnosed, a reoperation or other intervention will be performed. 56 patients will be enrolled to undergo the procedures. The IscAlert will be removed from the patient before the patient is discharged from the hospital or a maximum of 10 days (the event that occurs first). 360 devices are planned to be used in this clinical study.


Description:

This is an open, prospective, interventional, single-center clinical investigation designed to examine the feasibility and safety of the IscAlert™ device in patients scheduled for reconstructive flap surgery. 56 will be enrolled to undergo the procedures using a total of 350 devices depending on the injuries. IscAlert is 0.8 mm in diameter and in vitro testing, shows stable and accurate measurements of pCO2. More than 200 animal experiments have been done with the sensor. The experiments have shown that the sensor detects ischemia (Increased CO2-measurements) in real time in the following organs and tissues: Brain, heart, liver, kidneys, pancreas, intestines, musculature and subcutaneous tissue. Sensitivity and specificity are close to 100%. The sensors are inserted into tissue by a split needle technique. The split needle is the size of a 3-gauge peripheral venous catheter. In animal studies, no complications have been detected when using the sensor. The IscAlert sensors are connected to an electronics unit that is fixed to the skin with an adhesive plaster or glue outside the sterile area. The electrical signals are redirected to a PC approved for clinical use which continuously records tissue pressures of CO2. IscAlert is inserted into normal muscle and/or subcutaneous tissue distal on the reconstructed flap to be operated at the end of surgery. The insertion is far away from the operating field. The insertion is done under sterile conditions in accordance with standard sterility criteria at the hospital. No pain during insertion will occur because of insertion is performed during general anesthesia. Also, the insertion can be compared to an intramuscular injection. Postoperatively, the IscAlert sensor will continuously monitoring tissue CO2 and temperature. If ischemia occur, for examples caused by a thrombus, an increase in tissue CO2 and a lower temperature will evolve. This will be detected by the sensor which will alarm the investigators. This will lead to assessment of the reconstructed flap and if restricted blood flow is diagnosed, a reoperation or other intervention will be performed. The IscAlert will be removed from the patient before the patient is discharged from the hospital or a maximum of 10 days (the event that occurs first). Approximately 360 devices are planned to be used in this clinical study. One of the sensors will be used as a control inserted into neighboring tissue. The primary objective is to compare CO2-levels in the reconstructed flap in individuals who has undergone reconstructed flap surgery and investigate if CO2-level is different in patient diagnosed with obstructed blood flow vs. patients with sufficient blood flow in the reconstructed flap. Our hypotheses are: 1. The IscAlert™ device will be able to detect the presence of ischemia in the reconstructed flap by increased pCO2 levels and decrease in tissue temperature, measured by IscAlert™. 2. By using the IscAlert™ device monitoring ischemic events, an early treatment for ischemia could lead to higher incidence of reconstructed flap survival rates, and less revision surgery caused by thrombosis. 3. No clinically significant bleeding or infection will occur using IscAlert™ in this clinical study.


Recruitment information / eligibility

Status Recruiting
Enrollment 160
Est. completion date October 1, 2025
Est. primary completion date October 28, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients must be scheduled for reconstructive flap surgery - surgery - Patients must be = 18 years - Patients must be able to give written signed informed consent Exclusion Criteria: • Another study interfering with current study

Study Design


Intervention

Device:
IscAlert
Insertion of a CO2- and temperature sensor(s) in the reconstructed flap.

Locations

Country Name City State
Norway Oslo University Hospital Oslo

Sponsors (2)

Lead Sponsor Collaborator
Oslo University Hospital Sensocure AS

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Other Number of pack-years Smoking habit; number of pack-years by participants 30 days
Other Warm ischemia time Intraoperative ischemia time of the flap (minutes) 12 hours
Other Intravenous fluid Intravenous fluid given during surgery (ml) 12 hours
Other Vasoactive drugs Vasoactive drugs given during surgery (microgram) 12 hours
Other Arterial CO2 level Arterial blood gass analysis of CO2 during hospital stay (kPa) 10 days
Other Arterial PH level Arterial blood gass analysis of PH during hospital stay (kPa) 10 days
Other Arterial lactate level Arterial blood gass analysis of lactate during hospital stay (kPa) 10 days
Other Arterial HCO3 level Arterial blood gass analysis of HCO3 during hospital stay (kPa) 10 days
Other End-tidal level of CO2 End-tidal level of CO2 during hospital stay (kPa) 10 days
Other IscAlert functionality Number of hours with a well-functioning sensor (giving CO2- and temperature data) 10 days
Other Physical examination of the reconstructed flap - capillary filling Time of capillary filling (seconds) 10 days
Other Physical examination of the reconstructed flap - color Color of reimplanted extremity (Red or Pale) 10 days
Other Physical examination of the reconstructed flap - SpO2 SpO2 of reimplanted extremity (%) 10 days
Other Physical examination of the reconstructed flap - temperature Temperature of reimplanted extremity (degrees Celsius) 10 days
Other SpO2 SpO2 measured at a finger (%) 10 days
Other Examination of the reconstructed flap - Doppler Doppler flowmeter monitoring flow velocity in vascular flap bed (mL/min) 10 days
Primary Tissue CO2-level Tissue CO2-level (kPa) during insertion period 10 days
Secondary Bleeding Amount of blood from insertion site (ml) 10 days
Secondary Infection Infection from insertion site at the discretion of the investigator (yes or no) 30 days
Secondary Length of stay at hospital Number of days from end of initial operation to primary hospital discharge + Number of days from transfer from primary hospital to discharge from secondary hospital. 30 days
Secondary Time to reduced blood flow in reconstructed flap Number of days and hours from primary surgery end to obstructed blood flow is diagnosed 30 days
Secondary Number of re-operations Number of reoperations caused by replant necrosis/ischemia in the reconstructed flap 30 days
See also
  Status Clinical Trial Phase
Recruiting NCT05583916 - Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery N/A
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT03213314 - HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies N/A
Enrolling by invitation NCT05534490 - Surgery and Functionality in Older Adults N/A
Recruiting NCT04612491 - Pre-operative Consultation on Patient Anxiety and First-time Mohs Micrographic Surgery
Recruiting NCT04792983 - Cognition and the Immunology of Postoperative Outcomes
Recruiting NCT06397287 - PROM Project Urology
Recruiting NCT04444544 - Quality of Life and High-Risk Abdominal Cancer Surgery
Completed NCT04204785 - Noise in the OR at Induction: Patient and Anesthesiologists Perceptions N/A
Completed NCT03432429 - Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study
Completed NCT04176822 - Designing Animated Movie for Preoperative Period N/A
Recruiting NCT05370404 - Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain: N/A
Not yet recruiting NCT05467319 - Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS Phase 3
Recruiting NCT04602429 - Children's Acute Surgical Abdomen Programme
Completed NCT03124901 - Accuracy of Noninvasive Pulse Oximeter Measurement of Hemoglobin for Rainbow DCI Sensor N/A
Completed NCT04595695 - The Effect of Clear Masks in Improving Patient Relationships N/A
Recruiting NCT06103136 - Maestro 1.0 Post-Market Registry
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04059328 - Novel Surgical Checklists for Gynecologic Laparoscopy in Haiti
Recruiting NCT03697278 - Monitoring Postoperative Patient-controlled Analgesia (PCA) N/A